BPOM REALIZING CLINIC TEST DRUG COVID-19 NOT VALID

Head of Drug and Food Supervisory Agency (BPOM) Penny Kusumastuti Lukito (center) accompanied by Plt Expert Staff for National Innovation Research Agency / Head of Consortium Research and Innovation COVID-19 Ali Gufron Mukti (right) and members of the KOMNAS team of Drug Values and Tim Expert Rianto Setiabudy (left) provided press to journalists related to the development of new combination drug tests for COVID-19 in Jakarta, Wednesday (19/8/2020). BPOM’s head stated the test results of the three new combination drugs for COVID-19 the same work results of TNI AD, BIN and the University of Airlangga (Unair) is not valid, the party asked the researcher to revise and repair his research results in accordance with the predetermined use of BPOM. ANTARA FOTO/Nova Wahyudi/foc.

The caption is automatically translated by application. Click here for the Bahasa Indonesia version.